about
Investigational dopamine antagonists for the treatment of schizophrenia.Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases.Treatment of clozapine-associated weight gain: a systematic review.Glutamatergic agents for schizophrenia: current evidence and perspectives.Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.Electroconvulsive Therapy for Agitation in Schizophrenia: Metaanalysis of Randomized Controlled Trials.Cognitive impairment in schizophrenia: the great unmet need.The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades.Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder.SchizophreniaThe acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
P2860
Q36356306-EAEC99A0-3C2E-4F86-8B62-4F9A72403AA3Q37255533-BC0F66ED-CB7A-4D25-BC93-93BC205FF411Q38334922-7BDA40C1-F170-4246-8D18-35C1A235BE09Q38444551-98172ACC-8822-4B45-A18C-C1481DEB1F63Q38504254-292B9059-AFE2-4E02-AD94-AB20C04E5429Q38645819-FC1312C1-43FE-4AF1-A022-F4453ECDC975Q38673548-261682FB-6423-4A00-A83E-0EBE28B13132Q38674314-CEF0CE64-ED1E-4D4D-8A28-8E6080995185Q38718345-86C3F7A0-ECEC-45F0-90A3-205E8E0DD539Q39049252-BDFDCAD8-F07E-4CD3-A44C-E9875D5CDB83Q46395890-AE2710CC-12F4-4E8C-BD39-2CEEBB0AB391Q46800555-27A23D77-18A8-47F1-AD1A-EA477FEAB494Q52605626-A465DA23-D372-46B2-8316-576388AD143AQ56959104-4B4879A5-127D-480B-89D5-1928E8B8B1CEQ57817726-1D6B1BA6-3DD4-4FF3-A431-848F58FC855E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Emerging drugs for schizophrenia: an update.
@en
type
label
Emerging drugs for schizophrenia: an update.
@en
prefLabel
Emerging drugs for schizophrenia: an update.
@en
P2860
P1476
Emerging drugs for schizophrenia: an update.
@en
P2093
Christoph U Correll
Luisa-Sophie Köster
P2860
P304
P356
10.1517/14728214.2014.958148
P407
P50
P577
2014-09-19T00:00:00Z